US FDA News: FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer’s Disease

FDA today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease.
Read more: FDA Permits Marketing for New Test to Improve Diagnosis of Alzheimer’s Disease